Advertisement

Index by author

December 01, 1986; Volume 30,Issue 6

A

  1. Andrews, P A

    1. Differential sensitization of human ovarian carcinoma and mouse L1210 cells to cisplatin and melphalan by glutathione depletion.
      P A Andrews, M P Murphy and S B Howell
      Molecular Pharmacology December 1986, 30 (6) 643-650;

B

  1. Balestre, M N

    1. High yield photoaffinity labeling of angiotensin II receptors.
      G Guillemette, G Guillon, J Marie, M N Balestre, E Escher and S Jard
      Molecular Pharmacology December 1986, 30 (6) 544-551;

  2. Becker, C

    1. Studies on Ca channels in intact cardiac cells: voltage-dependent effects and cooperative interactions of dihydropyridine enantiomers.
      S Kokubun, B Prod'hom, C Becker, H Porzig and H Reuter
      Molecular Pharmacology December 1986, 30 (6) 571-584;

  3. Benavides, J

    1. The glycine receptor: pharmacological studies and mathematical modeling of the allosteric interaction between the glycine- and strychnine-binding sites.
      J C Marvizón, J Vázquez, M García Calvo, F Mayor, A Ruíz Gómez, F Valdivieso and J Benavides
      Molecular Pharmacology December 1986, 30 (6) 590-597;
    2. Activation and inhibition of 3H-strychnine binding to the glycine receptor by Eccles' anions: modulatory effects of cations.
      J C Marvizón, M García Calvo, J Vázquez, F Mayor, A Ruíz Gómez, F Valdiviesco and J Benavides
      Molecular Pharmacology December 1986, 30 (6) 598-602;

  4. Brown, J H

    1. Differences in muscarinic receptor reserve for inhibition of adenylate cyclase and stimulation of phosphoinositide hydrolysis in chick heart cells.
      J H Brown and D Goldstein
      Molecular Pharmacology December 1986, 30 (6) 566-570;

  5. Brown, O E

    1. Drug concentration-dependent DNA lesions are induced by the lipid-soluble antifolate, piritrexim (BW301U).
      R G Richards, O E Brown, M L Gillison and W D Sedwick
      Molecular Pharmacology December 1986, 30 (6) 651-658;

C

  1. Cannon, N J

    1. Binding of [3H]batrachotoxinin A benzoate to specific sites on rat cardiac sodium channels.
      R S Sheldon, N J Cannon and H J Duff
      Molecular Pharmacology December 1986, 30 (6) 617-623;

  2. Cantin, M

    1. Molecular characterization of the solubilized atrial natriuretic factor receptor from bovine adrenal zona glomerulosa.
      S Meloche, H Ong, M Cantin and A De Léan
      Molecular Pharmacology December 1986, 30 (6) 537-543;

  3. Cook, M

    1. Purification, characterization, and structural properties of a single protein from rat basophilic leukemia (RBL-1) cells possessing 5-lipoxygenase and leukotriene A4 synthetase activities.
      G K Hogaboom, M Cook, J F Newton, A Varrichio, R G Shorr, H M Sarau and S T Crooke
      Molecular Pharmacology December 1986, 30 (6) 510-519;

  4. Crooke, S T

    1. Purification, characterization, and structural properties of a single protein from rat basophilic leukemia (RBL-1) cells possessing 5-lipoxygenase and leukotriene A4 synthetase activities.
      G K Hogaboom, M Cook, J F Newton, A Varrichio, R G Shorr, H M Sarau and S T Crooke
      Molecular Pharmacology December 1986, 30 (6) 510-519;

  5. Crowe, V G

    1. LY195115: a potent, selective inhibitor of cyclic nucleotide phosphodiesterase located in the sarcoplasmic reticulum.
      R F Kauffman, V G Crowe, B G Utterback and D W Robertson
      Molecular Pharmacology December 1986, 30 (6) 609-616;

D

  1. De Léan, A

    1. Molecular characterization of the solubilized atrial natriuretic factor receptor from bovine adrenal zona glomerulosa.
      S Meloche, H Ong, M Cantin and A De Léan
      Molecular Pharmacology December 1986, 30 (6) 537-543;

  2. Dudycz, L W

    1. Ability of guanine nucleotide derivatives to bind and activate bovine transducin.
      D J Kelleher, L W Dudycz, G E Wright and G L Johnson
      Molecular Pharmacology December 1986, 30 (6) 603-608;

  3. Duff, H J

    1. Binding of [3H]batrachotoxinin A benzoate to specific sites on rat cardiac sodium channels.
      R S Sheldon, N J Cannon and H J Duff
      Molecular Pharmacology December 1986, 30 (6) 617-623;

E

  1. Eastmond, D A

    1. Metabolic activation of phenol by human myeloperoxidase and horseradish peroxidase.
      D A Eastmond, M T Smith, L O Ruzo and D Ross
      Molecular Pharmacology December 1986, 30 (6) 674-679;

  2. Escher, E

    1. High yield photoaffinity labeling of angiotensin II receptors.
      G Guillemette, G Guillon, J Marie, M N Balestre, E Escher and S Jard
      Molecular Pharmacology December 1986, 30 (6) 544-551;

  3. Ezumi, K

    1. Relationships of the molecular structure of aldosterone derivatives with their binding affinity for mineralocorticoid receptor.
      M Yamakawa, K Ezumi, M Shiro, H Nakai, S Kamata, T Matsui and N Haga
      Molecular Pharmacology December 1986, 30 (6) 585-589;

F

  1. Fok, K F

    1. Proteolytic processing of atriopeptin prohormone.
      M L Michener, J K Gierse, R Seetharam, K F Fok, P O Olins, M S Mai and P Needleman
      Molecular Pharmacology December 1986, 30 (6) 552-557;

G

  1. García Calvo, M

    1. The glycine receptor: pharmacological studies and mathematical modeling of the allosteric interaction between the glycine- and strychnine-binding sites.
      J C Marvizón, J Vázquez, M García Calvo, F Mayor, A Ruíz Gómez, F Valdivieso and J Benavides
      Molecular Pharmacology December 1986, 30 (6) 590-597;
    2. Activation and inhibition of 3H-strychnine binding to the glycine receptor by Eccles' anions: modulatory effects of cations.
      J C Marvizón, M García Calvo, J Vázquez, F Mayor, A Ruíz Gómez, F Valdiviesco and J Benavides
      Molecular Pharmacology December 1986, 30 (6) 598-602;

  2. Gierse, J K

    1. Proteolytic processing of atriopeptin prohormone.
      M L Michener, J K Gierse, R Seetharam, K F Fok, P O Olins, M S Mai and P Needleman
      Molecular Pharmacology December 1986, 30 (6) 552-557;

  3. Gillison, M L

    1. Drug concentration-dependent DNA lesions are induced by the lipid-soluble antifolate, piritrexim (BW301U).
      R G Richards, O E Brown, M L Gillison and W D Sedwick
      Molecular Pharmacology December 1986, 30 (6) 651-658;

  4. Goldstein, D

    1. Differences in muscarinic receptor reserve for inhibition of adenylate cyclase and stimulation of phosphoinositide hydrolysis in chick heart cells.
      J H Brown and D Goldstein
      Molecular Pharmacology December 1986, 30 (6) 566-570;

  5. Grab, L A

    1. Cooxidation of styrene by horseradish peroxidase and glutathione.
      P R Ortiz de Montellano and L A Grab
      Molecular Pharmacology December 1986, 30 (6) 666-669;

  6. Guillemette, G

    1. High yield photoaffinity labeling of angiotensin II receptors.
      G Guillemette, G Guillon, J Marie, M N Balestre, E Escher and S Jard
      Molecular Pharmacology December 1986, 30 (6) 544-551;

  7. Guillon, G

    1. High yield photoaffinity labeling of angiotensin II receptors.
      G Guillemette, G Guillon, J Marie, M N Balestre, E Escher and S Jard
      Molecular Pharmacology December 1986, 30 (6) 544-551;

H

  1. Haga, N

    1. Relationships of the molecular structure of aldosterone derivatives with their binding affinity for mineralocorticoid receptor.
      M Yamakawa, K Ezumi, M Shiro, H Nakai, S Kamata, T Matsui and N Haga
      Molecular Pharmacology December 1986, 30 (6) 585-589;

  2. Handler, J A

    1. Mechanism of zone-specific hepatic steatosis caused by valproate: inhibition of ketogenesis in periportal regions of the liver lobule.
      M J Olson, J A Handler and R G Thurman
      Molecular Pharmacology December 1986, 30 (6) 520-525;

  3. Hogaboom, G K

    1. Purification, characterization, and structural properties of a single protein from rat basophilic leukemia (RBL-1) cells possessing 5-lipoxygenase and leukotriene A4 synthetase activities.
      G K Hogaboom, M Cook, J F Newton, A Varrichio, R G Shorr, H M Sarau and S T Crooke
      Molecular Pharmacology December 1986, 30 (6) 510-519;

  4. Howell, S B

    1. Differential sensitization of human ovarian carcinoma and mouse L1210 cells to cisplatin and melphalan by glutathione depletion.
      P A Andrews, M P Murphy and S B Howell
      Molecular Pharmacology December 1986, 30 (6) 643-650;

J

  1. Jard, S

    1. High yield photoaffinity labeling of angiotensin II receptors.
      G Guillemette, G Guillon, J Marie, M N Balestre, E Escher and S Jard
      Molecular Pharmacology December 1986, 30 (6) 544-551;

  2. Jarvis, S M

    1. Nitrobenzylthioinosine-sensitive nucleoside transport system: mechanism of inhibition by dipyridamole.
      S M Jarvis
      Molecular Pharmacology December 1986, 30 (6) 659-665;

  3. Johnson, G L

    1. Ability of guanine nucleotide derivatives to bind and activate bovine transducin.
      D J Kelleher, L W Dudycz, G E Wright and G L Johnson
      Molecular Pharmacology December 1986, 30 (6) 603-608;

  4. Johnson, M D

    1. Vitamin D3 derivatives inhibit the differentiation of Friend erythroleukemia cells.
      J K Wang, M D Johnson, J I Morgan and S Spector
      Molecular Pharmacology December 1986, 30 (6) 639-642;

K

  1. Kamata, S

    1. Relationships of the molecular structure of aldosterone derivatives with their binding affinity for mineralocorticoid receptor.
      M Yamakawa, K Ezumi, M Shiro, H Nakai, S Kamata, T Matsui and N Haga
      Molecular Pharmacology December 1986, 30 (6) 585-589;

  2. Kauffman, R F

    1. LY195115: a potent, selective inhibitor of cyclic nucleotide phosphodiesterase located in the sarcoplasmic reticulum.
      R F Kauffman, V G Crowe, B G Utterback and D W Robertson
      Molecular Pharmacology December 1986, 30 (6) 609-616;

  3. Kelleher, D J

    1. Ability of guanine nucleotide derivatives to bind and activate bovine transducin.
      D J Kelleher, L W Dudycz, G E Wright and G L Johnson
      Molecular Pharmacology December 1986, 30 (6) 603-608;

  4. Kinnier, W J

    1. Ni-coupled receptors in cultured neural hybrid cells: cell specificity for dibutyryl cyclic AMP-induced down-regulation but not morphological differentiation.
      L Noronha-Blob, V C Lowe, W J Kinnier and D C U'Prichard
      Molecular Pharmacology December 1986, 30 (6) 526-536;

  5. Kokubun, S

    1. Studies on Ca channels in intact cardiac cells: voltage-dependent effects and cooperative interactions of dihydropyridine enantiomers.
      S Kokubun, B Prod'hom, C Becker, H Porzig and H Reuter
      Molecular Pharmacology December 1986, 30 (6) 571-584;

  6. Kontoghiorghes, G J

    1. Orally active alpha-ketohydroxypyridine iron chelators: studies in mice.
      G J Kontoghiorghes
      Molecular Pharmacology December 1986, 30 (6) 670-673;

L

  1. Lowe, V C

    1. Ni-coupled receptors in cultured neural hybrid cells: cell specificity for dibutyryl cyclic AMP-induced down-regulation but not morphological differentiation.
      L Noronha-Blob, V C Lowe, W J Kinnier and D C U'Prichard
      Molecular Pharmacology December 1986, 30 (6) 526-536;

  2. Luttrell, L M

    1. Hexose-independent activation of glycogen synthase and pyruvate dehydrogenase by insulin is dissociated in the mouse BC3H-1 cell line.
      L M Luttrell and A D Rogol
      Molecular Pharmacology December 1986, 30 (6) 624-630;

M

  1. Mai, M S

    1. Proteolytic processing of atriopeptin prohormone.
      M L Michener, J K Gierse, R Seetharam, K F Fok, P O Olins, M S Mai and P Needleman
      Molecular Pharmacology December 1986, 30 (6) 552-557;

  2. Marie, J

    1. High yield photoaffinity labeling of angiotensin II receptors.
      G Guillemette, G Guillon, J Marie, M N Balestre, E Escher and S Jard
      Molecular Pharmacology December 1986, 30 (6) 544-551;

  3. Marvizón, J C

    1. The glycine receptor: pharmacological studies and mathematical modeling of the allosteric interaction between the glycine- and strychnine-binding sites.
      J C Marvizón, J Vázquez, M García Calvo, F Mayor, A Ruíz Gómez, F Valdivieso and J Benavides
      Molecular Pharmacology December 1986, 30 (6) 590-597;
    2. Activation and inhibition of 3H-strychnine binding to the glycine receptor by Eccles' anions: modulatory effects of cations.
      J C Marvizón, M García Calvo, J Vázquez, F Mayor, A Ruíz Gómez, F Valdiviesco and J Benavides
      Molecular Pharmacology December 1986, 30 (6) 598-602;

  4. Masters, B S

    1. Substrate specificity of the rabbit lung flavin-containing monooxygenase for amines: oxidation products of primary alkylamines.
      L L Poulsen, K Taylor, D E Williams, B S Masters and D M Ziegler
      Molecular Pharmacology December 1986, 30 (6) 680-685;

  5. Matsui, T

    1. Relationships of the molecular structure of aldosterone derivatives with their binding affinity for mineralocorticoid receptor.
      M Yamakawa, K Ezumi, M Shiro, H Nakai, S Kamata, T Matsui and N Haga
      Molecular Pharmacology December 1986, 30 (6) 585-589;

  6. Mayor, F

    1. The glycine receptor: pharmacological studies and mathematical modeling of the allosteric interaction between the glycine- and strychnine-binding sites.
      J C Marvizón, J Vázquez, M García Calvo, F Mayor, A Ruíz Gómez, F Valdivieso and J Benavides
      Molecular Pharmacology December 1986, 30 (6) 590-597;
    2. Activation and inhibition of 3H-strychnine binding to the glycine receptor by Eccles' anions: modulatory effects of cations.
      J C Marvizón, M García Calvo, J Vázquez, F Mayor, A Ruíz Gómez, F Valdiviesco and J Benavides
      Molecular Pharmacology December 1986, 30 (6) 598-602;

  7. McLarnon, J G

    1. The actions of dimethyl sulfoxide on neuromuscular transmission.
      J G McLarnon, D A Saint and D M Quastel
      Molecular Pharmacology December 1986, 30 (6) 631-638;

  8. Meloche, S

    1. Molecular characterization of the solubilized atrial natriuretic factor receptor from bovine adrenal zona glomerulosa.
      S Meloche, H Ong, M Cantin and A De Léan
      Molecular Pharmacology December 1986, 30 (6) 537-543;

  9. Michener, M L

    1. Proteolytic processing of atriopeptin prohormone.
      M L Michener, J K Gierse, R Seetharam, K F Fok, P O Olins, M S Mai and P Needleman
      Molecular Pharmacology December 1986, 30 (6) 552-557;

  10. Miller, R J

    1. Widespread distribution of dihydropyridine-sensitive calcium channels in the central nervous system.
      S A Thayer, S N Murphy and R J Miller
      Molecular Pharmacology December 1986, 30 (6) 505-509;

  11. Morgan, J I

    1. Vitamin D3 derivatives inhibit the differentiation of Friend erythroleukemia cells.
      J K Wang, M D Johnson, J I Morgan and S Spector
      Molecular Pharmacology December 1986, 30 (6) 639-642;

  12. Murphy, M P

    1. Differential sensitization of human ovarian carcinoma and mouse L1210 cells to cisplatin and melphalan by glutathione depletion.
      P A Andrews, M P Murphy and S B Howell
      Molecular Pharmacology December 1986, 30 (6) 643-650;

  13. Murphy, S N

    1. Widespread distribution of dihydropyridine-sensitive calcium channels in the central nervous system.
      S A Thayer, S N Murphy and R J Miller
      Molecular Pharmacology December 1986, 30 (6) 505-509;

N

  1. Nakai, H

    1. Relationships of the molecular structure of aldosterone derivatives with their binding affinity for mineralocorticoid receptor.
      M Yamakawa, K Ezumi, M Shiro, H Nakai, S Kamata, T Matsui and N Haga
      Molecular Pharmacology December 1986, 30 (6) 585-589;

  2. Needleman, P

    1. Proteolytic processing of atriopeptin prohormone.
      M L Michener, J K Gierse, R Seetharam, K F Fok, P O Olins, M S Mai and P Needleman
      Molecular Pharmacology December 1986, 30 (6) 552-557;

  3. Newton, J F

    1. Purification, characterization, and structural properties of a single protein from rat basophilic leukemia (RBL-1) cells possessing 5-lipoxygenase and leukotriene A4 synthetase activities.
      G K Hogaboom, M Cook, J F Newton, A Varrichio, R G Shorr, H M Sarau and S T Crooke
      Molecular Pharmacology December 1986, 30 (6) 510-519;

  4. Noronha-Blob, L

    1. Ni-coupled receptors in cultured neural hybrid cells: cell specificity for dibutyryl cyclic AMP-induced down-regulation but not morphological differentiation.
      L Noronha-Blob, V C Lowe, W J Kinnier and D C U'Prichard
      Molecular Pharmacology December 1986, 30 (6) 526-536;

O

  1. Olins, P O

    1. Proteolytic processing of atriopeptin prohormone.
      M L Michener, J K Gierse, R Seetharam, K F Fok, P O Olins, M S Mai and P Needleman
      Molecular Pharmacology December 1986, 30 (6) 552-557;

  2. Olson, M J

    1. Mechanism of zone-specific hepatic steatosis caused by valproate: inhibition of ketogenesis in periportal regions of the liver lobule.
      M J Olson, J A Handler and R G Thurman
      Molecular Pharmacology December 1986, 30 (6) 520-525;

  3. Ong, H

    1. Molecular characterization of the solubilized atrial natriuretic factor receptor from bovine adrenal zona glomerulosa.
      S Meloche, H Ong, M Cantin and A De Léan
      Molecular Pharmacology December 1986, 30 (6) 537-543;

  4. Ortiz de Montellano, P R

    1. Cooxidation of styrene by horseradish peroxidase and glutathione.
      P R Ortiz de Montellano and L A Grab
      Molecular Pharmacology December 1986, 30 (6) 666-669;

P

  1. Porzig, H

    1. Studies on Ca channels in intact cardiac cells: voltage-dependent effects and cooperative interactions of dihydropyridine enantiomers.
      S Kokubun, B Prod'hom, C Becker, H Porzig and H Reuter
      Molecular Pharmacology December 1986, 30 (6) 571-584;

  2. Poulsen, L L

    1. Substrate specificity of the rabbit lung flavin-containing monooxygenase for amines: oxidation products of primary alkylamines.
      L L Poulsen, K Taylor, D E Williams, B S Masters and D M Ziegler
      Molecular Pharmacology December 1986, 30 (6) 680-685;

  3. Prod'hom, B

    1. Studies on Ca channels in intact cardiac cells: voltage-dependent effects and cooperative interactions of dihydropyridine enantiomers.
      S Kokubun, B Prod'hom, C Becker, H Porzig and H Reuter
      Molecular Pharmacology December 1986, 30 (6) 571-584;

  4. Puig, J F

    1. Isolation and purification of rat liver morphine UDP-glucuronosyltransferase.
      J F Puig and T R Tephly
      Molecular Pharmacology December 1986, 30 (6) 558-565;

Q

  1. Quastel, D M

    1. The actions of dimethyl sulfoxide on neuromuscular transmission.
      J G McLarnon, D A Saint and D M Quastel
      Molecular Pharmacology December 1986, 30 (6) 631-638;

R

  1. Reuter, H

    1. Studies on Ca channels in intact cardiac cells: voltage-dependent effects and cooperative interactions of dihydropyridine enantiomers.
      S Kokubun, B Prod'hom, C Becker, H Porzig and H Reuter
      Molecular Pharmacology December 1986, 30 (6) 571-584;

  2. Richards, R G

    1. Drug concentration-dependent DNA lesions are induced by the lipid-soluble antifolate, piritrexim (BW301U).
      R G Richards, O E Brown, M L Gillison and W D Sedwick
      Molecular Pharmacology December 1986, 30 (6) 651-658;

  3. Robertson, D W

    1. LY195115: a potent, selective inhibitor of cyclic nucleotide phosphodiesterase located in the sarcoplasmic reticulum.
      R F Kauffman, V G Crowe, B G Utterback and D W Robertson
      Molecular Pharmacology December 1986, 30 (6) 609-616;

  4. Rogol, A D

    1. Hexose-independent activation of glycogen synthase and pyruvate dehydrogenase by insulin is dissociated in the mouse BC3H-1 cell line.
      L M Luttrell and A D Rogol
      Molecular Pharmacology December 1986, 30 (6) 624-630;

  5. Ross, D

    1. Metabolic activation of phenol by human myeloperoxidase and horseradish peroxidase.
      D A Eastmond, M T Smith, L O Ruzo and D Ross
      Molecular Pharmacology December 1986, 30 (6) 674-679;

  6. Ruíz Gómez, A

    1. The glycine receptor: pharmacological studies and mathematical modeling of the allosteric interaction between the glycine- and strychnine-binding sites.
      J C Marvizón, J Vázquez, M García Calvo, F Mayor, A Ruíz Gómez, F Valdivieso and J Benavides
      Molecular Pharmacology December 1986, 30 (6) 590-597;
    2. Activation and inhibition of 3H-strychnine binding to the glycine receptor by Eccles' anions: modulatory effects of cations.
      J C Marvizón, M García Calvo, J Vázquez, F Mayor, A Ruíz Gómez, F Valdiviesco and J Benavides
      Molecular Pharmacology December 1986, 30 (6) 598-602;

  7. Ruzo, L O

    1. Metabolic activation of phenol by human myeloperoxidase and horseradish peroxidase.
      D A Eastmond, M T Smith, L O Ruzo and D Ross
      Molecular Pharmacology December 1986, 30 (6) 674-679;

S

  1. Saint, D A

    1. The actions of dimethyl sulfoxide on neuromuscular transmission.
      J G McLarnon, D A Saint and D M Quastel
      Molecular Pharmacology December 1986, 30 (6) 631-638;

  2. Sarau, H M

    1. Purification, characterization, and structural properties of a single protein from rat basophilic leukemia (RBL-1) cells possessing 5-lipoxygenase and leukotriene A4 synthetase activities.
      G K Hogaboom, M Cook, J F Newton, A Varrichio, R G Shorr, H M Sarau and S T Crooke
      Molecular Pharmacology December 1986, 30 (6) 510-519;

  3. Sedwick, W D

    1. Drug concentration-dependent DNA lesions are induced by the lipid-soluble antifolate, piritrexim (BW301U).
      R G Richards, O E Brown, M L Gillison and W D Sedwick
      Molecular Pharmacology December 1986, 30 (6) 651-658;

  4. Seetharam, R

    1. Proteolytic processing of atriopeptin prohormone.
      M L Michener, J K Gierse, R Seetharam, K F Fok, P O Olins, M S Mai and P Needleman
      Molecular Pharmacology December 1986, 30 (6) 552-557;

  5. Sheldon, R S

    1. Binding of [3H]batrachotoxinin A benzoate to specific sites on rat cardiac sodium channels.
      R S Sheldon, N J Cannon and H J Duff
      Molecular Pharmacology December 1986, 30 (6) 617-623;

  6. Shiro, M

    1. Relationships of the molecular structure of aldosterone derivatives with their binding affinity for mineralocorticoid receptor.
      M Yamakawa, K Ezumi, M Shiro, H Nakai, S Kamata, T Matsui and N Haga
      Molecular Pharmacology December 1986, 30 (6) 585-589;

  7. Shorr, R G

    1. Purification, characterization, and structural properties of a single protein from rat basophilic leukemia (RBL-1) cells possessing 5-lipoxygenase and leukotriene A4 synthetase activities.
      G K Hogaboom, M Cook, J F Newton, A Varrichio, R G Shorr, H M Sarau and S T Crooke
      Molecular Pharmacology December 1986, 30 (6) 510-519;

  8. Smith, M T

    1. Metabolic activation of phenol by human myeloperoxidase and horseradish peroxidase.
      D A Eastmond, M T Smith, L O Ruzo and D Ross
      Molecular Pharmacology December 1986, 30 (6) 674-679;

  9. Spector, S

    1. Vitamin D3 derivatives inhibit the differentiation of Friend erythroleukemia cells.
      J K Wang, M D Johnson, J I Morgan and S Spector
      Molecular Pharmacology December 1986, 30 (6) 639-642;

T

  1. Taylor, K

    1. Substrate specificity of the rabbit lung flavin-containing monooxygenase for amines: oxidation products of primary alkylamines.
      L L Poulsen, K Taylor, D E Williams, B S Masters and D M Ziegler
      Molecular Pharmacology December 1986, 30 (6) 680-685;

  2. Tephly, T R

    1. Isolation and purification of rat liver morphine UDP-glucuronosyltransferase.
      J F Puig and T R Tephly
      Molecular Pharmacology December 1986, 30 (6) 558-565;

  3. Thayer, S A

    1. Widespread distribution of dihydropyridine-sensitive calcium channels in the central nervous system.
      S A Thayer, S N Murphy and R J Miller
      Molecular Pharmacology December 1986, 30 (6) 505-509;

  4. Thurman, R G

    1. Mechanism of zone-specific hepatic steatosis caused by valproate: inhibition of ketogenesis in periportal regions of the liver lobule.
      M J Olson, J A Handler and R G Thurman
      Molecular Pharmacology December 1986, 30 (6) 520-525;

U

  1. U'Prichard, D C

    1. Ni-coupled receptors in cultured neural hybrid cells: cell specificity for dibutyryl cyclic AMP-induced down-regulation but not morphological differentiation.
      L Noronha-Blob, V C Lowe, W J Kinnier and D C U'Prichard
      Molecular Pharmacology December 1986, 30 (6) 526-536;

  2. Utterback, B G

    1. LY195115: a potent, selective inhibitor of cyclic nucleotide phosphodiesterase located in the sarcoplasmic reticulum.
      R F Kauffman, V G Crowe, B G Utterback and D W Robertson
      Molecular Pharmacology December 1986, 30 (6) 609-616;

V

  1. Valdiviesco, F

    1. Activation and inhibition of 3H-strychnine binding to the glycine receptor by Eccles' anions: modulatory effects of cations.
      J C Marvizón, M García Calvo, J Vázquez, F Mayor, A Ruíz Gómez, F Valdiviesco and J Benavides
      Molecular Pharmacology December 1986, 30 (6) 598-602;

  2. Valdivieso, F

    1. The glycine receptor: pharmacological studies and mathematical modeling of the allosteric interaction between the glycine- and strychnine-binding sites.
      J C Marvizón, J Vázquez, M García Calvo, F Mayor, A Ruíz Gómez, F Valdivieso and J Benavides
      Molecular Pharmacology December 1986, 30 (6) 590-597;

  3. Varrichio, A

    1. Purification, characterization, and structural properties of a single protein from rat basophilic leukemia (RBL-1) cells possessing 5-lipoxygenase and leukotriene A4 synthetase activities.
      G K Hogaboom, M Cook, J F Newton, A Varrichio, R G Shorr, H M Sarau and S T Crooke
      Molecular Pharmacology December 1986, 30 (6) 510-519;

  4. Vázquez, J

    1. The glycine receptor: pharmacological studies and mathematical modeling of the allosteric interaction between the glycine- and strychnine-binding sites.
      J C Marvizón, J Vázquez, M García Calvo, F Mayor, A Ruíz Gómez, F Valdivieso and J Benavides
      Molecular Pharmacology December 1986, 30 (6) 590-597;
    2. Activation and inhibition of 3H-strychnine binding to the glycine receptor by Eccles' anions: modulatory effects of cations.
      J C Marvizón, M García Calvo, J Vázquez, F Mayor, A Ruíz Gómez, F Valdiviesco and J Benavides
      Molecular Pharmacology December 1986, 30 (6) 598-602;

W

  1. Wang, J K

    1. Vitamin D3 derivatives inhibit the differentiation of Friend erythroleukemia cells.
      J K Wang, M D Johnson, J I Morgan and S Spector
      Molecular Pharmacology December 1986, 30 (6) 639-642;

  2. Williams, D E

    1. Substrate specificity of the rabbit lung flavin-containing monooxygenase for amines: oxidation products of primary alkylamines.
      L L Poulsen, K Taylor, D E Williams, B S Masters and D M Ziegler
      Molecular Pharmacology December 1986, 30 (6) 680-685;

  3. Wright, G E

    1. Ability of guanine nucleotide derivatives to bind and activate bovine transducin.
      D J Kelleher, L W Dudycz, G E Wright and G L Johnson
      Molecular Pharmacology December 1986, 30 (6) 603-608;

Y

  1. Yamakawa, M

    1. Relationships of the molecular structure of aldosterone derivatives with their binding affinity for mineralocorticoid receptor.
      M Yamakawa, K Ezumi, M Shiro, H Nakai, S Kamata, T Matsui and N Haga
      Molecular Pharmacology December 1986, 30 (6) 585-589;

Z

  1. Ziegler, D M

    1. Substrate specificity of the rabbit lung flavin-containing monooxygenase for amines: oxidation products of primary alkylamines.
      L L Poulsen, K Taylor, D E Williams, B S Masters and D M Ziegler
      Molecular Pharmacology December 1986, 30 (6) 680-685;
Back to top

In this issue